Tae‐Gyu Kim

Tae‐Gyu Kim

Auto-generated profile, based on publicly available information

Tae‐Gyu Kim

School of Healthcare and Biomedical Engineering Chonnam National University Yeosu 59626 Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2025 in Advanced Science
Verified
Journal Article
Open access
MKMin Jae Kim
Min Jae Kim
JYJiman Youn
Jiman Youn
HLHong Ju Lee
Hong Ju Lee
SLSeo-Yeon Lee
Seo-Yeon Lee
TKTae‐Gyu Kim
Tae‐Gyu Kim
HSHwa-Kyoung Shin
Hwa-Kyoung Shin
Ischemic brain injury not only results in significant neurological, motor, and cognitive impairment but also contributes to the accumulation of toxic solutes and proinflammatory cytokines in the infarction region, exacerbating ischemic brain damage. The glymphatic system, which is crucial for brain waste clearance and homeostasis, is impaired by ischemic injury, highlighting the importance of developing therapeutic strategies for poststroke complications. Herein, a novel hybrid electro‐optical stimulation device is proposed that integrates near‐infrared micro‐light‐emitting diode with transparent microneedles, enabling efficient noninvasive stimulation of the cortical area for ischemic stroke treatment. This study investigates whether this hybrid electro‐optical stimulation enhances the glymphatic system function and ameliorates ischemic brain injury in the middle cerebral artery occlusion and reperfusion (MCAO/R) mice model. The results demonstrate that hybrid stimulation improves the neurological, motor, and cognitive functions and reduces brain atrophy following MCAO/R. Moreover, hybrid stimulation restores impaired glymphatic system function by modulation of aquaporin‐4 (AQP4) polarization and alleviates the accumulation of proinflammatory cytokines such as IL‐1β. Notably, AQP4 inhibition partly reverses the improved functional outcomes of hybrid stimulation. The findings suggest that targeting glymphatic drainage using hybrid electro‐optical stimulation is a promising therapeutic approach for treating ischemic brain injury.